IHVN staff, stakeholders participating in a road walk from Jos road to Buka Sidi in Lafia, Nasarawa State.
(6th and 7th Left): Principal Investigator TICO Nigerian Study Center, Dr Nnakelu Eriobu and TICO Study Co-Investigator, Dr Vivian Kwaghe with TICO research study team at the Infectious Disease Center in University of Abuja Teaching Hospital (UATH), Abuja.
IHVN Senior Technical Advisor Pediatric and Adolescent HIV Dr. Nadia Sam Agudu training health care providers in Abuja, Nigeria
Findings from a multi-country study published in the Lancet Journal have revealed that concentrated solution of antibodies donated by patients who have recovered from COVID-19 is ineffective in treating hospitalized COVID-19 patients.
A recently published study involving researchers from the Institute of Human Virology Nigeria (IHVN), and Ahmadu Bello University, Zaria, Nigeria, has revealed that African children and adolescents hospitalized with COVID-19 experience high mortality rates.